A second course of antithyroid drug therapy for recurrent Graves' disease: An experience in endocrine practice

European Journal of Endocrinology

Volumn 172, Issue 3, 2015, Pages 321-326

  Liu, Xiaomei ^a   Qiang, Wei ^a   Liu, Xingjun ^a   Liu, Lianye ^a   Liu, Shu ^a   Gao, Aibo ^a   Gao, Shan ^a   Shi, Bingyin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; THIAMAZOLE; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; REMISSION; KAPLAN MEIER METHOD; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; CHILD; FEMALE; GRAVES DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84923649365     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0704     Document Type: Article

References (20)

1. Franklyn JA. The management of hyperthyroidism. New England Journal of Medicine 1994 330 1731-1738. (doi:10.1056/ NEJM199406163302407)
2. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Saaf M & Hamberger B. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. Thyroid Study Group. Journal of Clinical Endocrinology and Metabolism 1996 81 2986-2993.
3. Boelaert K. Treatment of Graves' disease with antithyroid drugs: current perspectives. Thyroid 2010 20 943-946. (doi:10.1089/thy.2010. 1654)
4. Weetman AP. Graves' disease. New England Journal of Medicine 2000 343 1236-1248. (doi:10.1056/NEJM200010263431707)
5. Cooper DS. Antithyroid drugs. New England Journal of Medicine 2005 352 905-917. (doi:10.1056/NEJMra042972)
6. Laurberg P, Krejbjerg A & Andersen SL. Relapse following antithyroid drug therapy for Graves' hyperthyroidism. Current Opinion in Endocrinology, Diabetes, and Obesity 2014 21 415-421. (doi:10.1097/MED. 0000000000000088)
7. Cooper DS. Hyperthyroidism. Lancet 2003 362 459-468. (doi:10.1016/ S0140-6736(03)14073-1)
8. Franklyn JA & Boelaert K. Thyrotoxicosis. Lancet 2012 379 1155-1166. (doi:10.1016/S0140-6736(11)60782-4)
9. Brent GA. Clinical practice. Graves' disease. New England Journal of Medicine 2008 358 2594-2605. (doi:10.1056/NEJMcp0801880)
10. Volpe R. The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: a review. Current Pharmaceutical Design 2001 7 451-460. (doi:10.2174/1381612013397898)
11. Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism? European Journal of Endocrinology 2006 155 783-786. (doi:10.1530/eje.1.02295)
12. Leger J, Gelwane G, Kaguelidou F, Benmerad M & Alberti C. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study. Journal of Clinical Endocrinology and Metabolism 2012 97 110-119. (doi:10.1210/jc.2011-1944)
13. Cooper DS. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. Journal of Clinical Endocrinology and Metabolism 2003 88 3474-3481. (doi:10.1210/jc.2003-030185)
14. Azizi F, Ataie L, Hedayati M, Mehrabi Y & Sheikholeslami F. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. European Journal of Endocrinology 2005 152 695-701. (doi:10.1530/eje.1.01904)
15. Shizume K. Long term antithyroid drug therapy for intractable cases of Graves' disease. Endocrinologia Japonica 1978 25 377-379. (doi:10.1507/ endocrj1954.25.377)
16. Slingerland DW & Burrows BA. Long-term antithyroid treatment in hyperthyroidism. Journal of the American Medical Association 1979 242 2408-2410. (doi:10.1001/jama.1979.03300220020015)
17. Lippe BM, Landaw EM & Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. Journal of Clinical Endocrinology and Metabolism 1987 64 1241-1245. (doi:10.1210/jcem-64-6-1241)
18. Anagnostis P, Adamidou F, Polyzos SA, Katergari S, Karathanasi E, Zouli C, Panagiotou A & Kita M. Predictors of long-term remission in patients with Graves' disease: a single center experience. Endocrine 2013 44 448-453. (doi:10.1007/s12020-013-9895-0)
19. Giuliani C, Cerrone D, Harii N, Thornton M, Kohn LD, Dagia NM, Bucci I, Carpentieri M, Di Nenno B, Di Blasio A et al. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment. Journal of Clinical Endocrinology and Metabolism 2012 97 E1080-E1087. (doi:10.1210/ jc.2011-2897)
20. RotondiM, Cappelli C, Pirali B, Pirola I, Magri F, Fonte R, CastellanoM, Rosei EA & Chiovato L. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. Journal of Clinical Endocrinology and Metabolism 2008 93 3985-3988. (doi:10.1210/jc.2008-0966)